Literature DB >> 23775395

Long-term outcomes for the endoscopic modified Lothrop/Draf III procedure: a 10-year review.

Yuresh Naidoo1, Ahmed Bassiouni, Mark Keen, Peter J Wormald.   

Abstract

OBJECTIVES/HYPOTHESIS: To detail the long-term outcomes of the endoscopic modified Lothrop procedure (EMLP) (also know as Draf III/frontal drillout) and identify key risk factors for failure. STUDY
DESIGN: Retrospective cohort study and chart review.
METHODS: Endoscopic assessment of frontal ostium patency and patient-reported symptoms were prospectively collected on patients who underwent EMLP between January 2001 and December 2011 for chronic rhinosinusitis (CRS). Risk factors for failing EMLP were identified.
RESULTS: There were 229 patients who met the inclusion and exclusion criteria and underwent an EMLP. The average number of standard endoscopic sinus surgery procedures prior to an EMLP was 3.8 (95% confidence interval [CI]: 3.4-4.2, standard deviation [SD]: 3.3).The average length of follow-up was 45.0 months (95% CI: 41.2-48.9 months, SD: 22.3 months). The EMLP was successful in 95% (217/229), with no further surgery being required. Postsurgical recurrence of disease with persistence of symptoms requiring revision EMLP occurred in 12 patients. No complications were identified. Allergic fungal sinusitis and recurrent Staphylococcus aureus infections were identified as potential risk factors for failure.
CONCLUSIONS: This is the single largest study of EMLP in the literature with a long follow-up period. It illustrates the benefit of the EMLP for patients with CRS recalcitrant to medical and standard endoscopic sinus surgery.
© 2013 The American Laryngological, Rhinological and Otological Society, Inc.

Entities:  

Keywords:  Draf III frontal sinus surgery; endoscopic modified Lothrop procedure; endoscopic sinus surgery; frontal drillout; frontal sinusotomy; outcomes; patency; risk factors

Mesh:

Year:  2013        PMID: 23775395     DOI: 10.1002/lary.24258

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  13 in total

Review 1.  Comprehensive review on endonasal endoscopic sinus surgery.

Authors:  Rainer K Weber; Werner Hosemann
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2015-12-22

2.  Prevalence of polyp recurrence after endoscopic sinus surgery for chronic rhinosinusitis with nasal polyposis.

Authors:  Adam S DeConde; Jess C Mace; Joshua M Levy; Luke Rudmik; Jeremiah A Alt; Timothy L Smith
Journal:  Laryngoscope       Date:  2016-11-12       Impact factor: 3.325

3.  The efficacy of extended Draf IIb procedure by partial nasal septectomy: long-term follow up.

Authors:  Ephraim Eviatar; Ahmed Taha; Haim Gavriel
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-04-03       Impact factor: 2.503

4.  Utility of flexible interventional endoscopy in endoscopic sinus surgery: a case series.

Authors:  Yann Litzistorf; François Gorostidi; Karma Lambercy; Antoine Reinhard
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-09-22       Impact factor: 3.236

Review 5.  Outcomes After Frontal Sinus Surgery: An Evidence-Based Review.

Authors:  Adam S DeConde; Timothy L Smith
Journal:  Otolaryngol Clin North Am       Date:  2016-08       Impact factor: 3.346

Review 6.  NSAID-ERD Syndrome: the New Hope from Prevention, Early Diagnosis, and New Therapeutic Targets.

Authors:  Tanya M Laidlaw; Joshua M Levy
Journal:  Curr Allergy Asthma Rep       Date:  2020-03-14       Impact factor: 4.806

7.  The endoscopic modified Lothrop procedure: finally ready for prime time in the management of inflammatory sinus disease.

Authors:  Timothy L Smith
Journal:  Int Forum Allergy Rhinol       Date:  2016-02-03       Impact factor: 3.858

8.  The endoscopic modified lothrop procedure: Review of single institution experience and long-term outcomes.

Authors:  Jasper Shen; Nadia Chan; Bozena B Wrobel
Journal:  Laryngoscope Investig Otolaryngol       Date:  2018-03-23

9.  Evaluation of a new and simple classification for endoscopic sinus surgery.

Authors:  Kengo Kanai; Mitsuhiro Okano; Takenori Haruna; Takaya Higaki; Ryotaro Omichi; Sei-Ichiro Makihara; Munechika Tsumura; Shin Kariya; Yuji Hirata; Kazunori Nishizaki
Journal:  Allergy Rhinol (Providence)       Date:  2017-10-01

Review 10.  Update on the Management of Nonsteroidal Anti-Inflammatory Drug Hypersensitivity.

Authors:  Wan Yin Winnie Yeung; Hae Sim Park
Journal:  Yonsei Med J       Date:  2020-01       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.